Have A Question?

Connect with Camargo today.

Contact Us
Blog & Resources Webinars The 505(b)(2) Pathway: Getting to the Clinic Faster

The 505(b)(2) Pathway: Getting to the Clinic Faster

Date: July 17th, 2019

Presented by: Ken Phelps, president and co-founder, Camargo


You’ve identified your product as a candidate for approval via the 505(b)(2) pathway and completed a successful pre-IND meeting. What comes next?

In part two of this webinar series on the 505(b)(2) pathway, Ken delves deeper into IND-enabling activities including CMC, toxicology and PK/PD. Discover tips for harnessing creativity to reference the right data, design and conduct the right studies and get your program to the clinic faster.

Get Our Diverse Expertise Working for You

To learn how you can benefit from our regulatory and strategic development expertise, view our Solutions or Contact Us.

Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.

9825 Kenwood Road
Suite 203
Cincinnati OH, 45242
Durham Office
800 Taylor Street
Suite 101
Durham NC, 27701
Montreal Office
507 Place d'Armes
Suite 1101
Montreal, QC H2Y 2W8, Canada
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights